Sheila Grant
Biochemistry
Jaguar Health
Canada
Biography
Ms. Sheila Grant currently serves as Cardiome’s Chief Operating Officer, with responsibility for overseeing Cardiome’s medical, regulatory and manufacturing operations. Ms. Grant was most recently Cardiome’s VP of Product Development, with responsibility for the overall management of the vernakalant IV and oral development programs from pre-clinical studies through to commercialization. Ms. Grant’s past roles at Cardiome have included VP Commercial Affairs, and Director of Business & Clinical Development. Prior to joining Cardiome, Ms. Grant acted as a business consultant to De Novo Enzyme Corporation and Coopers & Lybrand. Ms. Grant also worked in research and development, production, and quality assurance with Schering Agrochemicals U.K., Wellcome Biotechnologies U.K. and Serono Diagnostics U.K., respectively. Ms. Grant holds an MBA degree from Simon Fraser University.
Research Interest
Biochemistry
